JP2012528857A5 - - Google Patents

Download PDF

Info

Publication number
JP2012528857A5
JP2012528857A5 JP2012513928A JP2012513928A JP2012528857A5 JP 2012528857 A5 JP2012528857 A5 JP 2012528857A5 JP 2012513928 A JP2012513928 A JP 2012513928A JP 2012513928 A JP2012513928 A JP 2012513928A JP 2012528857 A5 JP2012528857 A5 JP 2012528857A5
Authority
JP
Japan
Prior art keywords
composition
composition according
lipid
peg
peg chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012513928A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012528857A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/001590 external-priority patent/WO2010141069A2/en
Publication of JP2012528857A publication Critical patent/JP2012528857A/ja
Publication of JP2012528857A5 publication Critical patent/JP2012528857A5/ja
Pending legal-status Critical Current

Links

JP2012513928A 2009-06-02 2010-06-01 純粋peg−脂質コンジュゲート Pending JP2012528857A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21762709P 2009-06-02 2009-06-02
US61/217,627 2009-06-02
US28406509P 2009-12-12 2009-12-12
US61/284,065 2009-12-12
PCT/US2010/001590 WO2010141069A2 (en) 2009-06-02 2010-06-01 Pure peg-lipid conjugates

Publications (2)

Publication Number Publication Date
JP2012528857A JP2012528857A (ja) 2012-11-15
JP2012528857A5 true JP2012528857A5 (enExample) 2013-08-15

Family

ID=43298359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012513928A Pending JP2012528857A (ja) 2009-06-02 2010-06-01 純粋peg−脂質コンジュゲート

Country Status (15)

Country Link
US (1) US20110040113A1 (enExample)
EP (1) EP2437756A2 (enExample)
JP (1) JP2012528857A (enExample)
KR (1) KR20120039564A (enExample)
CN (1) CN102665685A (enExample)
AP (1) AP2012006053A0 (enExample)
AU (1) AU2010257181A1 (enExample)
BR (1) BRPI1010175A2 (enExample)
CA (1) CA2763819A1 (enExample)
CL (1) CL2011003049A1 (enExample)
CO (1) CO6511284A2 (enExample)
IL (1) IL216719A0 (enExample)
MX (1) MX2011012823A (enExample)
WO (1) WO2010141069A2 (enExample)
ZA (1) ZA201109366B (enExample)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9393315B2 (en) 2011-06-08 2016-07-19 Nitto Denko Corporation Compounds for targeting drug delivery and enhancing siRNA activity
US20120202890A1 (en) 2011-02-08 2012-08-09 Nian Wu Polymer-carbohydrate-lipid conjugates
WO2012122144A1 (en) * 2011-03-07 2012-09-13 Wu Nian Highly monodisperse branched peg-lipid conjugates
US10196637B2 (en) 2011-06-08 2019-02-05 Nitto Denko Corporation Retinoid-lipid drug carrier
US8883177B2 (en) 2011-06-28 2014-11-11 Nian Wu Pharmaceutical compositions for parenteral administration
JP6051758B2 (ja) * 2011-10-17 2016-12-27 日油株式会社 ジアシルグリセロールと結合した分岐型ポリエチレングリコール、その製造方法およびポリエチレングリコール修飾リポソーム
PL2887958T3 (pl) 2012-08-21 2021-11-22 Opko Pharmaceuticals, Llc Formulacje liposomowe
US11458199B2 (en) 2012-08-21 2022-10-04 Opko Pharmaceuticals, Llc Liposome formulations
PL2887923T3 (pl) 2012-08-24 2023-08-14 Sun Pharmaceutical Industries Limited Preparat okulistyczny polioksylipidu lub polioksylowego kwasu tłuszczowego i leczenie chorób oczu
WO2015021044A1 (en) * 2013-08-05 2015-02-12 University Of Rochester Compositions and methods for stimuli-responsive release of a therapeutic agent
CN113274506A (zh) * 2013-12-05 2021-08-20 念·吴 聚合物-碳水化合物的缀合物的药物转递技术
JP6461973B2 (ja) * 2013-12-20 2019-01-30 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 2以上の疎水性ドメインおよびpeg部分を含む親水性ドメインを含む化合物の、細胞の安定化のための使用
ES2708360T3 (es) * 2013-12-20 2019-04-09 Hoffmann La Roche Compuestos que comprenden uno o más dominios hidrófobos y un dominio hidrófilo que comprende restos de PEG, útiles para unir células
WO2015091948A1 (en) 2013-12-20 2015-06-25 Roche Diagnostics Gmbh Method of immobilizing a cell on a support using compounds comprising a polyethylene glycol moiety
AU2015360794B2 (en) 2014-12-08 2021-07-08 The Board Of Regents Of The University Of Texas System Lipocationic polymers and uses thereof
US10064954B2 (en) * 2015-06-23 2018-09-04 Nian Wu Polymer-cyclodextrin-lipid conjugates
EP3349802B1 (en) 2015-09-14 2021-08-04 The Board of Regents of the University of Texas System Lipocationic dendrimers and uses thereof
JP2018532809A (ja) 2015-11-10 2018-11-08 サン ファーマ グローバル エフジーイー 局所製剤およびその使用
MD3386484T2 (ro) 2015-12-10 2022-11-30 Modernatx Inc Compoziții și metode de livrare a unor agenți terapeutici
CN106905120B (zh) * 2015-12-21 2020-04-28 北京键凯科技股份有限公司 Y型多缩乙二醇衍生物及其制备方法
DK3423076T3 (da) 2016-02-29 2024-07-08 Sun Pharmaceutical Ind Ltd Topisk cyclosporinholdige formuleringer og anvendelser deraf
CN109414451B (zh) 2016-05-16 2022-08-12 德克萨斯大学系统董事会 用于作为纳米粒递送tRNA的组合物及其使用方法
US10562849B2 (en) 2016-05-16 2020-02-18 The Board Of Regents Of The University Of Texas System Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
KR102546103B1 (ko) * 2018-03-20 2023-06-21 니치유 가부시키가이샤 분기형 단분산 폴리에틸렌 글리콜, 중간체 및 그 제조 방법
CN111936549B (zh) * 2018-03-29 2023-03-10 日油株式会社 包含三苯甲基的单分散聚乙二醇的纯化方法
WO2019191597A1 (en) * 2018-03-30 2019-10-03 The Board Of Regents Of The University Of Oklahoma Very long chain saturated fatty acid compounds, compositions containing same, and methods of use
US12357580B2 (en) 2018-06-19 2025-07-15 The Board Of Regents Of The University Of Texas System Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids
EP3846857A4 (en) 2018-09-04 2022-10-12 The Board Of Regents Of The University Of Texas System COMPOSITIONS AND METHODS FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACIDS
GB2592505B (en) 2018-09-04 2023-05-03 Univ Texas Compositions and methods for organ specific delivery of nucleic acids
EP4509118A3 (en) * 2018-09-19 2025-05-14 ModernaTX, Inc. High-purity peg lipids and uses thereof
JP6805385B1 (ja) * 2020-08-31 2020-12-23 ジェイ−ネットワーク,インコーポレイテッド 表皮内の保湿関連物質の発現増強剤
IL320367A (en) 2020-10-09 2025-06-01 Univ Texas Prefusion-stabilized hmpv f proteins
JP6860739B1 (ja) * 2020-11-20 2021-04-21 ジェイ−ネットワーク,インコーポレイテッド 表皮内の抗酸化物質の発現増強剤
CN114685778B (zh) * 2020-12-30 2023-10-17 苏州艾博生物科技有限公司 长循环阳离子脂质体的合成方法
US20240123076A1 (en) 2021-02-08 2024-04-18 The Board Of Regents Of The University Of Texas System Unsaturated dendrimers compositions, related formulations, and methods of use thereof
AU2022242828A1 (en) 2021-03-23 2023-10-12 Recode Therapeutics, Inc. Polynucleotide compositions, related formulations, and methods of use thereof
CA3215509A1 (en) 2021-04-22 2022-10-27 Daniel J. Siegwart All-in-one dendrimer-based lipid nanoparticles enable precise hdr-mediated gene editing in vivo
CN114276535B (zh) 2021-06-30 2022-06-21 天津键凯科技有限公司 聚乙二醇脂质及其应用
CN113461929B (zh) * 2021-07-13 2023-04-21 浙江倍合德制药有限公司 一种tpgs系列产品的精制提纯方法
CN116410460B (zh) * 2021-12-29 2025-08-05 辅必成(上海)医药科技有限公司 一种1,2-二肉豆蔻酰-rac-甘油-3-甲氧基聚乙二醇2000的制备方法
CN114507342B (zh) * 2022-03-18 2024-03-19 江苏东南纳米材料有限公司 一种1,2-二肉豆蔻酰-rac-甘油-3-甲氧基聚乙二醇及其中间体的制备方法
EP4504265A1 (en) * 2022-04-05 2025-02-12 Capstan Therapeutics, Inc. Peg-lipids and lipid nanoparticles
CN114524943B (zh) * 2022-04-22 2022-09-16 天津凯莱英制药有限公司 聚乙二醇-甘油衍生物及其中间体各自的制备方法
CN117003807A (zh) * 2022-04-28 2023-11-07 北京科兴中维生物技术有限公司 一种结构脂质化合物及其制备方法和用途
JP2025539101A (ja) * 2022-11-15 2025-12-03 エボニック オペレーションズ ゲーエムベーハー ポリオキシアルキレンがc1~c3-アルキルオキシメチル側鎖を有するポリ(エチレンオキシド)である、ポリオキシアルキレン-1,2-ジミリストイル-グリセロール化合物
CN120693181A (zh) 2022-12-08 2025-09-23 瑞科德治疗公司 脂质纳米颗粒组合物及其用途
IL321992A (en) 2023-01-09 2025-09-01 Univ Texas Human parainfluenza virus 3f proteins stabilized before transfusion
CN116178733B (zh) * 2023-03-03 2023-08-01 浙江博美生物技术有限公司 一种基于三官能团氨基酸的支化单分散peg衍生物、制备方法和应用
US12364773B2 (en) 2023-12-01 2025-07-22 Recode Therapeutics, Inc. Lipid nanoparticle compositions and uses thereof
WO2025137646A1 (en) 2023-12-22 2025-06-26 Recode Therapeutics, Inc. Gene editing methods and compositions for treating cystic fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827533A (en) * 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants
US7141552B2 (en) * 2000-01-10 2006-11-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
EP1664316B1 (en) * 2003-09-15 2012-08-29 Protiva Biotherapeutics Inc. Polyethyleneglycol-modified lipid compounds and uses thereof
US20060051405A1 (en) * 2004-07-19 2006-03-09 Protiva Biotherapeutics, Inc. Compositions for the delivery of therapeutic agents and uses thereof
CA2629330C (en) * 2004-11-12 2018-05-22 Cambridge University Technical Services Ltd. Methods and means related to cancer stem cells
AU2008321174A1 (en) * 2007-11-14 2009-05-22 The Regents Of The University Of California Sterol-modified amphiphilic lipids

Similar Documents

Publication Publication Date Title
JP2012528857A5 (enExample)
Chen et al. Self-assembly cationic nanoparticles based on cholesterol-grafted bioreducible poly (amidoamine) for siRNA delivery
Palmerston Mendes et al. Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy
Guo et al. Self-assembly and paclitaxel loading capacity of cellulose-graft-poly (lactide) nanomicelles
Lee et al. Polyplexes assembled with internally quaternized PAMAM-OH dendrimer and plasmid DNA have a neutral surface and gene delivery potency
Jain et al. A new horizon in modifications of chitosan: syntheses and applications
Di Gianvincenzo et al. Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents
Chai et al. Delivery of oridonin and methotrexate via PEGylated graphene oxide
WO2011163483A3 (en) Polymers for biomaterials and therapeutics
WO2012040184A3 (en) Novel low molecular weight cationic lipids for oligonucleotide delivery
WO2011043913A3 (en) Novel cationic lipids with short lipid chains for oligonucleotide delivery
Wang et al. Host–guest chemistry of dendrimer–cyclodextrin conjugates: selective encapsulations of guests within dendrimer or cyclodextrin cavities revealed by NOE NMR techniques
WO2009114368A3 (en) Activated nitric oxide donors and methods of making and using thereof
Zhang et al. Cationic dendron-bearing lipids: Investigating structure–activity relationships for small interfering RNA delivery
WO2009074678A3 (en) Anticancer conjugates of camptothecin to hyaluronic acid
WO2011153493A3 (en) Biodegradable lipids for the delivery of active agents
JP2012255007A5 (enExample)
WO2010147655A3 (en) Compositions and methods relating to nucleic acid delivery vehicles
IN2014DN00101A (enExample)
WO2012054365A3 (en) Novel low molecular weight cationic lipids for oligonucleotide delivery
US10058620B2 (en) Dextran-peptide hybrid for efficient gene delivery
JP2015517466A5 (enExample)
JP2013510181A5 (enExample)
Gaspar et al. Biofunctionalized nanoparticles with pH-responsive and cell penetrating blocks for gene delivery
Sarisozen et al. Recent advances in siRNA delivery